Transcranical photobiomodulation (tPBM, 1267 nm, 32 J/cm2) is effective non-invasive method for clearance of beta-amyloid from the brain in mice with Alzheimer’s disease and for improvemen of their neurological status.
Oxana V. Semyachkina-Glushkovskaya, Ekaterina Zinchenko, Maria Klimova, Andrey Terskov, Arkady Abdurashitov, Alexander Dubrovsky, Inna Blokhina, Alexander Khorovodov, Ilana Agranovich, Nikita Navolokin, Alexander Shirokov, Elena Saranceva, Aysel Mamedova, Valery Tuchin, and Juergen Kurths, "Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease (Conference Presentation)," Proc. SPIE 11241, Biophotonics and Immune Responses XV, 1124103 (Presented at SPIE BiOS: February 03, 2020; Published: 6 March 2020); https://doi.org/10.1117/12.2541561.6138714127001.
Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease (Conference Presentation)
Authors: Oxana V. Semyachkina-Glushkovskaya et al.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for most presentations.
Search our growing collection of more than 27,500 conference presentations, including many plenaries and keynotes.